Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cadd4 effectively reduces cholesterol levels without side effects.

Technological advancements and standardization are crucial for improving diagnostic accuracy and laboratory efficiency.

Women aged 21-26 have a higher rate of PCOS.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Higher cholesterol levels increase aggressive prostate cancer risk.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

Vitamin E and C may help slow Alzheimer's and Parkinson's progression.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Combining metformin with amoxicillin/clavulanate lowers blood sugar in diabetic female rats.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Men with early hair loss may have higher health risks similar to women with PCOS.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The research developed new fortilin protein constructs for potential heart disease treatments.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Isotretinoin effectively treats acne with low risk if dosed correctly.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Oral minoxidil 7.5 mg for hair loss increases heart rate but not blood pressure.